These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1365017)

  • 1. Purging of autologous bone marrow for transplantation: the protection and selection of the hematopoietic progenitor cell.
    Shpall EJ; Stemmer SM; Johnston CF; Hami L; Bearman SI; Berenson R; Jones RB
    J Hematother; 1992; 1(1):45-54. PubMed ID: 1365017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G-CSF primed peripheral blood progenitor cells in autologous bone marrow transplantation: parameters affecting bone marrow engraftment.
    Bolwell BJ; Fishleder A; Andresen SW; Lichtin AE; Koo A; Yanssens T; Burwell R; Baucco P; Green R
    Bone Marrow Transplant; 1993 Dec; 12(6):609-14. PubMed ID: 7511016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future paradigm for autologous bone marrow transplantation: tumor purging and ex vivo production of normal stem and progenitor cells.
    Rummel SA; Van Zant G
    J Hematother; 1994; 3(3):213-8. PubMed ID: 7827869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graft purging in autologous bone marrow transplantation: a promise not quite fulfilled.
    Alvarnas JC; Forman SJ
    Oncology (Williston Park); 2004 Jun; 18(7):867-76; discussion 876-8, 881, 884. PubMed ID: 15255171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
    Sun J; Wu B; Liu Q; Feng R; Liu X; Meng F; Zhou S
    Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New developments in stem cell detection and stem cell selection in the context of autologous transplantations.
    Douay L; Lopez M; Giarratana MC; Bony V; Bouchet S; Gorin NC
    Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):87-9. PubMed ID: 8099734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
    De Rosa L; Lalle M; Pandolfi A; Ruscio C; Amodeo R
    Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of amifostine in bone marrow purging.
    Cagnoni PJ; Jones RB; Bearman SI; Ross M; Hami L; Franklin WA; Capizzi R; Schein PS; Shpall EJ
    Semin Oncol; 1996 Aug; 23(4 Suppl 8):44-8. PubMed ID: 8783666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purging in autologous and allogeneic bone marrow transplantation.
    Gulati SC; Lemoli RM; Acaba L; Igarashi T; Wasserheit C; Fraig M
    Curr Opin Oncol; 1992 Apr; 4(2):264-71. PubMed ID: 1591301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sensitivity of leukemic bone marrow to simvastatin is lost at remission: a potential purging agent for autologous bone marrow transplantation.
    Newman A; Clutterbuck RD; DeLord C; Powles RL; Catovsky D; Millar JL
    J Investig Med; 1995 Jun; 43(3):269-74. PubMed ID: 7614073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous bone marrow transplantation for leukemia.
    Stuart RK
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):40-54. PubMed ID: 8211215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo manipulation of hematopoietic stem cells for transplantation: the potential role of amifostine.
    Balzarotti M; Grisanti S; Granzow K; Saladini A; Sala A; Nozza A; Molteni A; Passamonti F; Carlo-Stella C; Santoro A; Siena S
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):66-71. PubMed ID: 10348263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased sensitivity of myeloid leukemia cell lines: potential of lovastatin as bone-marrow-purging agent.
    Scheffold C; Schöttker B; Lefterova P; Csipai M; Glasmacher A; Huhn D; Neubauer A; Schmidt-Wolf IG
    Acta Haematol; 2000; 104(2-3):72-9. PubMed ID: 11154978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
    Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
    Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cytotoxicity of alkyl-lysophospholipid on clonogenic leukemia cells and on normal bone marrow progenitor cells is highly, but differentially, increased by cryopreservation.
    Verdonck LF; Heesbeen EC; van Heugten HG; Staal GE; Rijksen G
    Bone Marrow Transplant; 1992 Apr; 9(4):241-5. PubMed ID: 1600412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro purging of bone marrow for autologous marrow transplantation in acute myelogenous leukemia using myeloid-specific monoclonal antibodies.
    Ball ED
    Bone Marrow Transplant; 1988 Sep; 3(5):387-92. PubMed ID: 3056546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful autologous transplantation of immunomagnetic bead purged bone marrow in non-Hodgkin's lymphoma.
    Ogniben E; Hohaus S; Kvalheim G; Dörken B; Haas R
    Prog Clin Biol Res; 1992; 377():189-95. PubMed ID: 1438415
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of autologous bone marrow transplantation in non-Hodgkin's lymphoma.
    Vose JM; Armitage JO
    Hematol Oncol Clin North Am; 1993 Jun; 7(3):577-90. PubMed ID: 8102135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of purging clonogenic leukemia cells using ether lipid and hyperthermia for autologous bone marrow transplantation.
    Min WS; Park HM; Han CH; Park JW; Kim CC; Kim DJ
    Prog Clin Biol Res; 1992; 377():87-95. PubMed ID: 1438449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.